{"data":[{"accessionNo":"0000919574-26-005266","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001434647","issuerName":"Zevra Therapeutics, Inc.","ticker":"ZVRA","cusip":"488445206","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Woodline Partners LP","reportingCik":null,"personType":"IA,PN","sharesOwned":4785771,"percentOfClass":8.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0000315066-26-002197","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS INC","ticker":"ZVRA","cusip":"488445206","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":4915717,"percentOfClass":8.3,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0000315066-26-002197","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS INC","ticker":"ZVRA","cusip":"488445206","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":4915717,"percentOfClass":8.3,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0002100119-26-001518","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001434647","issuerName":"Zevra Therapeutics Inc","ticker":"ZVRA","cusip":"488445206","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":3024980,"percentOfClass":5.11,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0000315066-26-001339","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS INC","ticker":"ZVRA","cusip":"488445206","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":3211876.51,"percentOfClass":5.5,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0000315066-26-001339","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS INC","ticker":"ZVRA","cusip":"488445206","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":3211876.51,"percentOfClass":5.5,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0000102909-26-002639","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001434647","issuerName":"Zevra Therapeutics Inc","ticker":"ZVRA","cusip":"488445206","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0000902664-25-005021","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001434647","issuerName":"ZEVRA THERAPEUTICS, INC.","ticker":"ZVRA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Woodline Partners LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3476143,"percentOfClass":6.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0000902664-25-004878","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001434647","issuerName":"Zevra Therapeutics, Inc.","ticker":"ZVRA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":2225000,"percentOfClass":3.96,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0000902664-25-004878","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001434647","issuerName":"Zevra Therapeutics, Inc.","ticker":"ZVRA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":2225000,"percentOfClass":3.96,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"},{"accessionNo":"0000902664-25-004878","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001434647","issuerName":"Zevra Therapeutics, Inc.","ticker":"ZVRA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":2225000,"percentOfClass":3.96,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/zvra"}],"updatedAt":"2026-11-04T00:26:48.278Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/zvra","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}